CommercialCoverageMedium impact
07.13.11k, Contact Lenses for the Treatment of Persistent (Corneal) Epithelial Defects
Independence Blue Cross·Ophthalmology, Optometry·Medical Policy
Effective date
Dec 10, 2025
We identified it
Jun 19, 2026
Summary
This is a reissued medical policy (effective 12/10/2025) covering contact lens treatment for persistent corneal epithelial defects. The billing team must review the full policy text to identify any coverage criteria changes, prior authorization requirements, or billing code updates that may affect claim submission and reimbursement for this therapeutic contact lens service.
Action Required
By December 10, 2025: Billing team must obtain and review the full policy text at the provided URL (https://medpolicy.ibx.com/ibc/Commercial/Pages/Site-Activity-View.aspx?FilterField1=MPSiteActivityLogMonth&FilterValue1=12&FilterField2=MPSiteActivityLogYear&FilterValue2=2025#commercial-07-13-11k) to identify specific coverage criteria, prior authorization requirements, and applicable billing codes for contact lenses treating persistent corneal epithelial defects. Update billing system rules, encounter forms, and provider guidance documents accordingly. Communicate any changes to providers and front-desk staff. Failure to implement required prior authorization or documentation requirements will result in claim denials.